Cargando…
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL
Activated B cell–like diffuse large B-cell lymphomas (ABC-DLBCL) have unfavorable outcomes and chronic activation of CARD11–BCL10–MALT1 (CBM) signal amplification complexes that form due to polymerization of BCL10 subunits, which is affected by recurrent somatic mutations in ABC-DLBCLs. Herein, we s...
Autores principales: | Xia, Min, David, Liron, Teater, Matt, Gutierrez, Johana, Wang, Xiang, Meydan, Cem, Lytle, Andrew, Slack, Graham W., Scott, David W., Morin, Ryan D., Onder, Ozlem, Elenitoba-Johnson, Kojo S.J., Zamponi, Nahuel, Cerchietti, Leandro, Lu, Tianbao, Philippar, Ulrike, Fontan, Lorena, Wu, Hao, Melnick, Ari M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357155/ https://www.ncbi.nlm.nih.gov/pubmed/35658124 http://dx.doi.org/10.1158/2159-8290.CD-21-1566 |
Ejemplares similares
-
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
por: Li, Meng, et al.
Publicado: (2022) -
Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule
por: Abbott, David R., et al.
Publicado: (2009) -
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015) -
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
por: Roh, Jin, et al.
Publicado: (2020) -
The transcriptional modulator BCL6 as a molecular target for breast cancer therapy
por: Walker, Sarah R., et al.
Publicado: (2014)